3 result(s) displayed (1 - 3 of 3):

Tobin leaves Boston Sci dented by deals (from Corporate Dealmaker)

Few people in the M&A world need to be reminded that acquisitions often go wrong. But it's still useful to reflect on the ways that can happen. And the retirement of Jim Tobin as CEO of medical devices maker Boston Scientific Corp. (NYSE:BSX), announced Thursday, is a good occasion to...

Posted on June 25, 2009 12:16 PM

Corporate Venture Capital: Medical Device Mania (from Corporate Dealmaker)

"At Guidant, we never made an investment at any company without the notion that if things went well, we would acquire it."

Posted on August 15, 2007 4:55 PM

The Boston Sci-Guidant deal revisited (from Corporate Dealmaker)

Viewed from a patent perspective, the acquisition makes a little more sense -- for both offensive and defensive reasons.

Posted on December 15, 2006 10:02 PM